Bristol-Myers Squibb
Health Care |
Pharmaceutical Companies
New York, NY 10154-0101
Recent News About Bristol-Myers Squibb
-
BMS won’t be much of a precedent if it’s stretched to the point of meaninglessness.
-
WASHINGTON (Legal Newsline) – Since last year’s U.S. Supreme Court ruling that dealt a blow to forum-shopping personal injury attorneys, companies threatened with sprawling, 50-state litigation have not been forced into defending cases all over the country.
-
While the U.S. Supreme Court's Bristol Myers Squibb ruling has resulted in some big wins for businesses targeted by the plaintiffs' bar, new strategies and theories deployed by plaintiffs' lawyers may be blunting the further impact of that decision, despite high hopes from some it would largely thwart the ability of out-of-state plaintiffs to sue out-of-state defendants in a favorable court forum.
-
ST. LOUIS - Legal experts following the Johnson & Johnson talcum powder lawsuits in St. Louis say that even in the face of Monday’s declared mistrial of one of the cases on jurisdictional grounds, many of the hundreds of other cases will drag on “because so much money is involved.”
-
WASHINGTON – Supreme Court Justices have put an end to mass actions in state courts against two or more defendants, according to a dissent they don’t dispute.
-
WASHINGTON – The U.S. Supreme Court has overturned rulings made by three California courts that concluded they had specific jurisdiction over lawsuits brought by out-of-state residents against a company not incorporated or headquartered there.
